E. Kim Mulholland, Don Bandaranayake, Samuel Kariuki, Muriel Dufour, Elizabeth de Pinna, Peter J. Hart, Take Toleafoa Naseri, David J. Edwards, Amy K. Cain, Derek Pickard, Robert S. Heyderman, Chisomo L. Msefula, Julian Parkhill, Jacqueline A. Keane, David A. B. Dance, Jane Hawkey, Nga Tran Vu Thieu, Conall H. Watson, Paul N. Newton, Viengmon Davong, Elizabeth J. Klemm, W. John Edmunds, James Campbell, Shanta Dutta, Andrew J. Page, Christopher M. Parry, Nicholas A. Feasey, Nicholas R. Thomson, Lupeoletalalei Isaia, Duy Pham Thanh, François-Xavier Weill, Kylie Jenkins, Satheesh Nair, Sabina Dongol, Florian Marks, Stephen Baker, Lalith Wijedoru, Calman A. MacLennan, Robert A. Kingsley, Eric J. Nilles, Josefina Campos, Christiane Dolecek, Shalini Singh, John A. Crump, Dafni A. Glinos, Simon R. Harris, Stephen K. Obaro, José A. Chabalgoity, Mochammad Hatta, Paul Turner, Melita A. Gordon, Octavie Lunguya, Jan Jacobs, Guy E. Thwaites, Sona Soeng, Karolina Dimovski, Vanessa K. Wong, Karen H. Keddy, Geoff Hogg, Mary Valcanis, Buddha Basnyat, Corinne N. Thompson, James Hadfield, Mike Kama, Abhilasha Karkey, Kathryn E. Holt, Robert S. Onsare, Anthony M. Smith, Alison E. Mather, Chinyere K. Okoro, Joan Powling, Robert F. Breiman, Jeremy Farrar, Gordon Dougan, The Wellcome Trust Sanger Institute [Cambridge], Addenbrooke's Hospital, Cambridge University NHS Trust, Oxford University Clinical Research Unit [Ho Chi Minh City] (OUCRU), University of Oxford [Oxford], London School of Hygiene and Tropical Medicine (LSHTM), Liverpool School of Tropical Medicine (LSTM), Institute of Food Research [Norwich], Bactéries pathogènes entériques (BPE), Institut Pasteur [Paris], University of Melbourne, University of Birmingham [Birmingham], Kenya Medical Research Institute (KEMRI), Centers for Disease Control and Prevention [Atlanta] (CDC), Centers for Disease Control and Prevention, Emory Global Health Institute [Atlanta] (EGHI), Emory University [Atlanta, GA], University of Liverpool, University of Malawi, Institute of Tropical Medicine [Antwerp] (ITM), Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven), Institut National de Recherche Biomédicale [Kinshasa] (INRB), University of Kinshasa (UNIKIN), Universidad de Montevideo, Ministry of Health [Fiji], National Institute of Cholera and Enteric Diseases, International Vaccine Institute (IVI), Administración Nacional de Laboratorios e Institutos de Salud ‘Carlos Malbran' (ANLIS), University of Nebraska Medical Center, University of Nebraska System, University of Abuja, Bingham University, Novartis Vaccines Institute for Global Health (NVGH), University of the Witwatersrand [Johannesburg] (WITS), Nagasaki University, Murdoch Children's Research Institute (MCRI), Oxford University Clinical Research Unit [Kathmandu], Institute of Environmental Science and Research (ESR), Ministry of Health [Samoa], Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), Hasanuddin University (Unhas), Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Mahidol University [Bangkok]-Mahosot Hospital, Tupua Tamasese Meaole Hospital (TTM), Mahidol University [Bangkok], Chelsea and Westminster Hospital, University of Otago [Dunedin, Nouvelle-Zélande], Public Health England [London], Angkor Hospital for Children (AHC), The Peter Doherty Institute for Infection and Immunity [Melbourne], University of Melbourne-The Royal Melbourne Hospital, This work was supported by a number of organizations. The authors affiliated with the Wellcome Trust Sanger Institute were funded by Wellcome Trust award 098051, N.A.F. was supported by Wellcome Trust research fellowship WT092152MA. N.A.F., R.S.H. and this work were supported by a strategic award from the Wellcome Trust for the Malawi-Liverpool Wellcome Trust Clinical Research Programme (101113/Z/13/Z). C.M.P. was funded by the Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme, supported by the Wellcome Trust (Major Overseas Programmes–Thailand Unit Core Grant), the European Society for Paediatric Infectious Diseases and the University of Oxford–Li Ka Shing Global Health Foundation. D.D., P.N. and V.D. were supported by the Wellcome Trust (core grant 089275/H/09/Z). K.E.H. was supported by the National Health and Medical Research Council of Australia (fellowship 1061409) and the Victorian Life Sciences Computation Initiative (VLSCI, grant VR0082). C.A.M. was supported by a Clinical Research Fellowship from GlaxoSmithKline, and P.J.H. was supported by a UK Medical Research Council PhD studentship. This work forms part of a European Union Framework Programme 7 Marie Curie Actions Industry Academia Partnerships and Pathways (IAPP) Consortium Programme, entitled GENDRIVAX (Genome-Driven Vaccine Development for Bacterial Infections), involving the Wellcome Trust Sanger Institute, KEMRI Nairobi and the Novartis Vaccines Institute for Global Health. The authors affiliated with the Institut Pasteur were funded by the Institut Pasteur, the Institut de Veille Sanitaire and the French government 'Investissement d'Avenir' program (Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence, grant ANR-10-LABX-62-IBEID). C.H.W. was supported by the UK Medical Research Council (MR/J003999/1). C.O. was supported by Society in Science and the Branco Weiss Fellowship, administered by ETH Zurich. A.K.C. was supported by the UK Medical Research Council (G1100100/1). J.J. was supported by the antibiotic resistance surveillance project in the Democratic Republic of the Congo, funded by project 2.01 of the Third Framework Agreement between the Belgian Directorate General of Development Cooperation and the Institute of Tropical Medicine (Antwerp, Belgium). F.M. was supported by a research grant from the Bill and Melinda Gates Foundation. The findings and conclusions contained within this publication are those of the authors and do not necessarily reflect positions or policies of the Bill and Melinda Gates Foundation. J.A. Crump was supported by the joint US National Institutes of Health–National Science Foundation Ecology and Evolution of Infectious Disease program (R01 TW009237), the UK Biotechnology and Biological Sciences Research Council (BBSRC, BB/J010367/1) and UK BBSRC Zoonoses in Emerging Livestock Systems awards BB/L017679, BB/L018926 and BB/L018845. S.K. was supported by US National Institutes of Health grant R01 AI099525-02. S.B. is a Sir Henry Dale Fellow, jointly funded by the Wellcome Trust and the Royal Society (100087/Z/12/Z). S.O. was supported by the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health (R01 AI097493). The content is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. C.D. was supported by the University of Oxford–Li Ka Shing Global Health Foundation., Baker, Stephen [0000-0003-1308-5755], Parkhill, Julian [0000-0002-7069-5958], Marks, Florian [0000-0002-6043-7170], Dougan, Gordon [0000-0003-0022-965X], Apollo - University of Cambridge Repository, University of Oxford, Biotechnology and Biological Sciences Research Council (BBSRC), and Institut Pasteur [Paris] (IP)